Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
4DMedical Ltd ( (AU:4DX) ) has issued an announcement.
4DMedical has applied for quotation on the ASX of 485,976 new fully paid ordinary shares, to be issued on 18 March 2026 under the ticker 4DX. The move modestly increases the company’s listed share capital and reflects the conversion of existing options or other convertible securities, which may slightly enhance liquidity for investors without materially changing its capital structure.
The additional quotation of securities indicates ongoing utilisation of equity-based instruments within 4DMedical’s funding and incentive mix. While the size of this issuance is relatively small, it underscores continued shareholder engagement and may support incremental trading volume in the company’s stock on the Australian market.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$4.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is an Australian-listed medical technology company trading on the ASX under the code 4DX. The company focuses on developing and commercialising respiratory imaging technologies and related diagnostic solutions that assist in assessing lung function and improving clinical decision-making in pulmonary medicine.
Average Trading Volume: 6,812,628
Technical Sentiment Signal: Buy
Current Market Cap: A$2.17B
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.